On Friday, Vir Biotechnology, Inc. (NASDAQ:VIR) announced end-of-treatment data from Part B of the MARCH Phase 2 study ...

Hepatitis C is a viral infection that causes inflammation and damage to the liver, requiring a liver transplant if not ...

Renowned Tamil filmmaker Suresh Sangaiah passed away in Chennai on Friday, November 15, at the Rajiv Gandhi Hospital, ...

Understanding the symptoms of cirrhosis can facilitate early diagnosis and intervention, improving outcomes for those ...

Precision BioSciences (DTIL) will present preclinical data supporting the advancement of PBGENE-HBV into clinical development. The company will ...

Arbutus Biopharma (ABUS) and Barinthus Biotherapeutics (BRNS) announced new preliminary data from the Phase 2a IM-PROVE II clinical trial of ...

HBsAg levels less than 1000 IU/mL achieved functional cure in Cohort A1 of the IM-PROVE I Phase 2a clinical trial Overall, in Cohort A1, 25% of patients achieved functional ...

BioSafe Systems and LIVENTIA are excited to announce a partnership that will bring LIVENTIA's advanced microbial inoculants to BioSafe Systems' Restorative Soils Programtm. This collaboration combines ...

Obsidian Solutions Group, a leading provider of mission-critical defense training systems and solutions, is pleased to announce its participation in the 2024 Interservice/Industry Training, Simulation ...

Researchers develop a plug-and-play test that enables real-time monitoring of engineered T-cells, improving the precision and ...

A novel test enables real-time monitoring of T cells that have been engineered to fight cancer, after re-introduction into the body of a cancer patient. This simple and innovative test provides ...

During a Case-Based Roundtable® event, Patrick M. Forde, MD, discussed safety and tolerability concerns with immunotherapy in ...